Outpatient intravenous sotalol load to replace 3-day admission oral sotalol load
Nicholas H Von Bergen, Arij G Beshish, Kathleen R Maginot, Nicholas H Von Bergen, Arij G Beshish, Kathleen R Maginot
No abstract availableKeywords: Arrhythmias; Congenital heart disease; Intravenous; Potassium channel blockers; Sotalol.
References
- Samanta R., Thiagalingam A., Turner C., Lakkireddy D.J., Kovoor P. The use of intravenous sotalol in cardiac arrhythmias. Heart, Lung and Circulation. 2018;27:1318–1326.
- Kim M.H., Klingman D., Lin J., Pathak P., Battleman D.S. Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation. Ann Pharmacother. 2009;43:840–848.
- Sheikh A., Patel N.J., Nalluri N. Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future. Prog Cardiovasc Dis. 2015;58:105–116.
- Tang K., Mattingly T.J., II, Ayres J., See V., Reed B. Cost-minimization analysis of atrial fibrillation and atrial flutter through intravenous sotalol loading. J Am Coll Cardiol. 2018;71:A491.
- Ho D.S., Zecchin R.P., Cooper M.J., Richards D.A., Uther J.B., Ross D.L. Rapid intravenous infusion of d-1 sotalol: time to onset of effects on ventricular refractoriness, and safety. Eur Heart J. 1995;16:81–86.
- Yarlagadda B., Vuddanda V., Dar T. Safety and efficacy of inpatient initiation of dofetilide versus sotalol for atrial fibrillation. J Atr Fibrillation. 2017;10:1805.
Source: PubMed